Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 15.36B |
| Enterprise Value | 16.8B |
| P/E Ratio | -11.72 |
| PEG Ratio | -0.64 |
| Price/Sales Ratio | 14.52 |
| Price/Book Ratio | 101.01 |
| Enterprise/Revenue | 16.8 |
| Enterprise/EBITDA | -15.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.23 |
| Operating Margin | -1.17 |
| Return On Assets | -0.2 |
| Return On Equity | -1.81 |
| Revenue | 662.52M |
| Revenue/Share | 1.87 |
| Gross Profit | 662.52M |
| EBITDA | -860.38M |
| Net Income | -970.18M |
| Diluted EPS | -2.43 |
| Total Cash | 1.49B |
| Total Cash/Share | 3.74 |
| Total Debt | 3.19B |
| Total Debt/Equity | 29.86 |
| Current Ratio | 0.88 |
| Book Value Per Share | 0.73 |
| 52-Week Change | 9.5 |
| 52-Week High | 63.59 |
| 52-Week Low | 22.4 |
| Moving Average 50 Days | 33.26 |
| Moving Average 200 Days | 39.07 |
| Average Volume | 9.24M |
| Shares Outstanding | 399.6M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.07 |
| Last Split Factor | N/A |
| Last Split Date | N/A |